Clinical Trial

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study tests how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 study treatments in this study, participants will get either NNC0662-0419, the treatment being tested or placebo, a treatment that has no active medicine in it. NNC0662-0419 is a new medicine which cannot be pre-scribed by doctors but has previously been tested in humans.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-09-18; most recent amendment 2026-05-06.
Status change: Recruiting → Active, Not Recruiting 2026-04-24
Status change: Not Yet Recruiting → Recruiting 2025-10-20
Trial Details
NCT Number NCT07184632
Lead Sponsor Novo Nordisk A/S
Conditions Overweight, Obesity
Enrollment 224 participants
Start Date 2025-10-01
Primary Completion 2026-12-14 (estimated)
Study Completion 2026-12-14 (estimated)
Updated on ClinicalTrials.gov 2026-05-07